HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: Pharma
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
Adalimumab is a medicine that belongs to the class of biologic DMARDs (disease-modifying antirheumatic medications). Humira is a common brand name used in marketing.
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
Semaglutide Semaglutide is a drug developed by Novo Nordisk in 2012, used to treat type 2 diabetes and obesity and is marketed under the brand names Ozempic, Wegovy, and Rybelsus….
-
FDA approved Leqembi to have $12.9 billion sales
Leqembi (lecanemab), a recently approved medicine from Biogen/Eisai for the treatment of Alzheimer’s disease, was given FDA approval in January 2023
-
Antimicrobial Resistance: Top 10 worldwide public health hazards
Antimicrobial Resistance (AMR) is a condition in which bacteria, viruses, fungi, and parasites evolve over time and cease to respond to antibiotics, making infections more difficult to cure and raising the risk of disease transmission as it then associated with being a life-threatening sickness and/or even death. Drug resistance makes it harder or impossible to…
-
Bulk Drug Park Scheme; Attempt to capture Pharmaceutical Industry to 1.4 trillion USD market
Bulk Drug Park Scheme. Indian pharmaceutical exports include a sizeable portion of bulk medications and intermediates. According to Pharmexil’s Annual Report 2020, the export numbers for APIs range roughly from 3525-3867 million USD during a 3 year period. The three nations receiving the biggest percentages of Indian API exports, both in terms of volume and…
-
5+ Impactful Uses of Enterprise Resource Planning (ERP) System in Healthcare
ERP for hospital management systems plays a vital role in reducing clinical errors and enhancing operations through increased efficiency and coordinated data analyses. Artificial intelligence (AI) has made a significant impact on the healthcare industry, changing how we identify, treat, and monitor patients.
-
Paxlovid: The Ultimate Antiviral Pill
Introduction Paxlovid, the pill that has become the go-to treatment for COVID-19 treatment, was granted full approval in May by the Food And Drug Administration (FDA) for the treatment of mild-to-moderate…
-
CAR-T CELL to witness CAGR of 11.37% growth
CAR-T CELL to witness CAGR of 11.37% growth
-
GSK acquires Tesaro for $5.1 Billion – The market is buzzing
GSK acquires Tesaro for $5.1 Billion – The market is buzzing
-
GUT HEALTH : PROBIOTICS AND PREBIOTICS
A healthy gut plays a vital role in the overall health of an individual. Our gut is home to millions of bacteria which we call as microbiota. These bacteria that…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila